Patients affected by SSc-ILD and diffuse cutaneous involvement exhibited higher median titres of anti-CXCR3 and anti-CXCR4 antibodies vs. limited cutaneous SSc (lcSSc) and healthy controls. This evidence concerns the gene CXCR3 and systemic sclerosis.